WellSyncs network of qualified clinicians will conduct consultations, manage treatments, and oversee patient care
[Doctor & Pharmacist Formulated] Developed under professional guidance for effective, responsible support
10.1021/acs.est.6b01974 Environ
, at the University College in London
What Are GLP-1, GIP, and GLP-3
Authors Lucas Oliveira, Nutritionist, ProVeg International Anna-Lena Klapp, Head of Research, ProVeg International We would like to thank the following people for sharing their time, expertise, and thoughtful review of the brochure: Valentina Gallani, Health & Nutrition Manager, ProVeg International Veronika Mlynrik Baov, Senior Nutrition Specialist, ProVeg Czech Republic Laura Weinhold, Dietitian & Food Services Specialist, ProVeg Germany Stefany Guerreiro Lima, Food and Nutrition Project Manager, ProVeg Brasil References WHO issues global guideline on the use of GLP-1 medicines in treating obesity